Regentatlantic Capital LLC Charles River Laboratories International, Inc. Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
A detailed history of Regentatlantic Capital LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 1,071 shares of CRL stock, worth $201,240. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,071
Previous 1,147
6.63%
Holding current value
$201,240
Previous $245,000
13.88%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$703 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$400 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...